Study of Infections in Patients With Autoimmune Diseases Treated With Rituximab
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Autoimmune Diseases
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03778840
- Collaborators
- Grifols Biologicals, LLC
- Investigators
- Principal Investigator: Vincent SOBANSKI, MD, PhD University Hospital, Lille